Replimune Group officer proposes $1.66M stock sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. (REPL) reports that officer Konstantinos Xynos gave notice of a proposed sale of 83,758 common shares, with an aggregate market value of $1,659,246 and an approximate sale date of November 19, 2026. The notice lists August 20, 2026 as the Rule 10b5-1 plan adoption or instruction date and identifies J.P. Morgan Securities LLC as broker.
Key Figures
Key Terms
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When was Konstantinos Xynos's REPL sale plan adopted?
AI-generated analysis. How Rhea-AI works. Not financial advice.